Medicare Enrolled
Dr. Saravanan Balamuthusamy, M.D.
Internal Medicine · Fort Worth, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Balamuthusamy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Balamuthusamy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Balamuthusamy
Dr. Saravanan Balamuthusamy is an internal medicine specialist in Fort Worth, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Balamuthusamy performed 2,416 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Balamuthusamy received a total of $416,399 from 45 pharmaceutical and/or device companies across 596 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Balamuthusamy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 15% volume in TX
$416,399 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,416
Medicare services
Top 15% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$176
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
214 | $234 | $500 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
171 | $0 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
167 | $84 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
158 | $90 | $400 |
| Injection, fentanyl citrate, 0.1 mg | 155 | $1 | $15 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
153 | $39 | $250 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
142 | $0 | $20 |
| Ultrasound of hemodialysis access An ultrasound imaging test used to evaluate the blood flow and structure of a hemodialysis access site. |
135 | $99 | $700 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
130 | $9 | $50 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
125 | $52 | $300 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
93 | $113 | $800 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
88 | $187 | $700 |
| Hemodialysis circuit intervention with balloon dilation A procedure to insert a needle or tube into a hemodialysis circuit and dilate the dialysis segment using a balloon, with radiological review. |
76 | $905 | $5,100 |
| Arterial catheter insertion, first order branch Placement of a catheter into a primary branch of an artery in the chest or arm. |
50 | $443 | $4,100 |
| Ultrasound of blood vessel, initial vessel An ultrasound exam of a blood vessel that includes a radiologist's review of the initial vessel. |
49 | $750 | $2,500 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
49 | $111 | $700 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
46 | $50 | $300 |
| Balloon dilation of dialysis access with radiologist review A minimally invasive procedure to widen a narrowed section of a dialysis access vessel using a balloon catheter. The procedure includes review by a radiologist to ensure proper placement and effectiveness. |
37 | $468 | $3,100 |
| Additional blood vessel ultrasound evaluation An ultrasound exam of a blood vessel that includes a radiologist's review. This code applies to each additional vessel evaluated beyond the initial one. |
34 | $134 | $900 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
32 | $1 | $50 |
| Cefazolin sodium injection, 500 mg An injection of 500 mg of cefazolin sodium, an antibiotic medication, administered into the body. |
31 | $1 | $5 |
| Contrast injection for X-ray imaging Administration of a contrast agent into a vein in the arm or leg to enhance visibility during an X-ray imaging procedure. |
29 | $183 | $1,400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $133 | $500 |
| Hemodialysis circuit intervention with stent placement A radiologist inserts a needle or tube into the hemodialysis circuit and places a stent in the dialysis segment while reviewing the procedure. |
25 | $3,404 | $23,000 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
25 | $31 | $150 |
| Needle or tube insertion into hemodialysis circuit with radiologist review A procedure involving the insertion of a needle or tube into a hemodialysis circuit, accompanied by a review of the procedure by a radiologist. |
24 | $490 | $2,500 |
| Injection, lorazepam, 2 mg | 24 | $1 | $5 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
20 | $62 | $300 |
| Removal of tunneled central venous tube This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein. |
19 | $97 | $700 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
18 | $80 | $350 |
| Balloon dilation of vein, initial vein A procedure to widen a vein using a balloon catheter, with radiologist review. |
15 | $1,024 | $6,000 |
| Radiologist review of major upper body vein image A radiologist reviews images of the major veins in the upper body to assess their structure and function. |
15 | $81 | $600 |
| Review by radiologist of both arms and legs veins of both arms or legs image | 14 | $92 | $600 |
| Pre-op ultrasound of artery and vein blood flow for hemodialysis access An ultrasound exam to assess blood flow in the arteries and veins on both sides of the body before surgery for hemodialysis access. |
14 | $196 | $800 |
| Replacement of tunneled central venous tube This procedure involves replacing an existing tunneled central venous catheter with a new one. The new tube is inserted through the same tunnel under the skin to maintain vascular access. |
13 | $310 | $2,900 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.9% high complexity
55.5% medium
37.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$416,399
Total received (2018-2024)
Avg $59,486/year across 7 years
Top 0% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
596
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$83,817
2023
$111,051
2022
$70,715
2021
$25,612
2020
$19,599
2019
$75,238
2018
$30,367
Payments by company (2024)
Amgen Inc.
$42,294
Travere Therapeutics, Inc.
$26,284
SOBI, INC
$8,751
Merit Medical Systems Inc
$3,000
Vifor Pharma, Inc.
$2,823
Bard Peripheral Vascular, Inc.
$325
CorMedix Inc.
$59
Boston Scientific Corporation
$55
Medtronic, Inc.
$54
Bayer Healthcare Pharmaceuticals Inc.
$44
AngioDynamics, Inc.
$34
Tactile Systems Technology Inc
$27
AKEBIA THERAPEUTICS INC
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Novartis Pharmaceuticals Corporation
$20
Top 3 companies account for 92.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$82,304
Travere Therapeutics, Inc.
$69,254
Janssen Pharmaceuticals, Inc
$47,475
Vifor Pharma, Inc.
$40,922
Relypsa, Inc.
$40,496
Bard Peripheral Vascular, Inc.
$40,491
Horizon Therapeutics plc
$34,127
W. L. Gore & Associates, Inc.
$17,453
AstraZeneca Pharmaceuticals LP
$10,699
SOBI, INC
$8,751
GlaxoSmithKline, LLC.
$6,078
BARD PERIPHERAL VASCULAR, INC.
$5,886
Outset Medical Inc
$4,500
Merit Medical Systems Inc
$3,000
Otsuka America Pharmaceutical, Inc.
$1,634
C. R. Bard, Inc. & Subsidiaries
$900
Medtronic Vascular, Inc.
$484
Cardiovascular Systems Inc.
$216
Bayer HealthCare Pharmaceuticals Inc.
$179
Abbott Laboratories
$158
Bayer Healthcare Pharmaceuticals Inc.
$138
Boston Scientific Corporation
$125
Mallinckrodt LLC
$121
Philips Electronics North America Corporation
$112
Aurinia Pharma U.S., Inc.
$102
Medtronic, Inc.
$99
Alexion Pharmaceuticals, Inc.
$88
OPKO Pharmaceuticals, LLC
$75
NxStage Medical, Inc.
$71
CorMedix Inc.
$59
Tactile Systems Technology Inc
$52
Ultragenyx Pharmaceutical Inc.
$42
Fresenius USA Marketing, Inc.
$40
AKEBIA THERAPEUTICS INC
$36
AngioDynamics, Inc.
$34
CashFlow Solutions, LLC
$26
Calliditas Therapeutics US Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Alnylam Pharmaceuticals Inc.
$22
CALLIDITAS THERAPEUTICS US INC.
$22
Novartis Pharmaceuticals Corporation
$20
Cardinal Health 200, LLC
$17
Amicus Therapeutics, Inc.
$16
Daiichi Sankyo Inc.
$15
Arrow International, Inc.
$12
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
(6578) Visions 018 · ACTHAR · ACUSEAL Vascular Graft · AURYON LASER SYSTEM 100-120 VAC · Auryxia · BENLYSTA · CLOSUREFAST · COVERA · CROSSER · CRYSVITA · Catheter - Turnpike · ClosureFast · DefenCath · Diamondback Peripheral · ELLIPSYS VASCULAR ACCESS SYSTEM · FARXIGA · FLEXITOUCH · FLUENCY · Flexitouch Plus · Fluency · Fluency Endovascular Stent Graft · GALAFOLD · GORE VIABAHN VBX Balloon Expandable Endo · IN.PACT Admiral · INJECTAFER · INVOKANA · Image Guided Therapy Devices _ Peripheral · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · LUTONIX · Lympha Press Optimal Plus(US) BT · MynxGrip Vascular Closure Device · OXLUMO · PROCLAIM · Parsabiv · Peripheral Orbital Atherectomy System · Peritoneal Dialysis Systems · RAYALDEE · Rayaldee · SAMSCA · SYNAGIS · System One · TARPEYO · TAVNEOS · Tavneos · ULTOMIRIS · VENASEAL · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with PROPATEN Bioactive Surface · Vafseo · Varithena Administration Pack · Velphoro · Veltassa · VenaSeal · WAVELINQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
905
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Balamuthusamy is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Balamuthusamy experienced with home dialysis services per month?
Based on Medicare claims data, Dr. Balamuthusamy performed 214 home dialysis services per month services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Balamuthusamy receive payments from pharmaceutical companies?
Yes. Dr. Balamuthusamy received a total of $416,399 from 45 companies across 596 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Balamuthusamy's costs compare to other internal medicine physicians in Fort Worth?
Dr. Balamuthusamy's average Medicare payment per service is $176. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Balamuthusamy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Fort Worth
Browse internal medicine physicians in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Travere Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Travere Therapeutics, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology